Skip to main content
Account

Peer review reports

From: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Original Submission
22 Jul 2019 Submitted Original manuscript
25 Aug 2019 Author responded Author comments - Carole Mercier
Resubmission - Version 2
25 Aug 2019 Submitted Manuscript version 2
Publishing
26 Aug 2019 Editorially accepted
4 Sep 2019 Article published 10.1186/s12885-019-6097-z

Learn about peer review

Back to article page

Navigation